Author:
Dinarello Alberto,May Makenna,Amo-Aparicio Jesus,Azam Tania,Gaballa Joseph M,Marchetti Carlo,Tesoriere Annachiara,Ghirardo Rachele,Redzic Jasmina S,Webber William,Atif Shaikh M,Li Suzhao,Eisenmesser Elan Z,de Graaf Dennis M,Dinarello Charles A
Abstract
AbstractThe IL-1 Family member IL-38 has been characterized primarily as an anti-inflammatory cytokine in human and mouse models of systemic diseases. Here, we examined the role of IL-38 in the murine small intestine (SI). Immunostaining of SI revealed that IL-38 expression partially confines to intestinal stem cells. Cultures of intestinal organoids reveal IL-38 functions as a growth factor by increasing organoid size via inducing WNT3a. In contrast, organoids from IL-38 deficient mice develop more slowly. This reduction in size is likely due to downregulation of intestinal stemness markers (i.e.,Fzd5,Ephb2,Olfm4) expression compared with wild type organoids. IL-38 binding to IL-1R6 is postulated to recruit the co-receptor IL-1R9. Therefore, to analyze the molecular mechanisms of IL-38 signaling, we also examined organoids from IL-1R9 deficient mice. Unexpectedly, these organoids, although significantly smaller than wild type, respond to IL-38, suggesting that IL-1R9 is not involved in IL-38 signaling in the stem cell crypt. Nevertheless, silencing of IL-1R6 disabled the organoid response to the growth property of IL-38, thus suggesting IL-1R6 as the main receptor used by IL-38 in the crypt compartment. In organoids from wild type mice, IL-38 stimulation induced low concentrations of IL-1β which contribute to organoid growth. However, high concentrations of IL-1β have detrimental effects on the cultures that were prevented by treatment with recombinant IL-38. Overall, our data demonstrate an important regulatory function of IL-38 as a growth factor, and as an anti-inflammatory molecule in the SI, maintaining homeostasis.SignificanceThe IL-1 family member IL-38 has been characterized primarily as an anti-inflammatory cytokine for systemic diseases. Here we describe a fundamental role of IL-38 in driving intestinal stem cell differentiation through the upregulation of WNT3a and IL-1β. Our findings reveal a dual role of IL-38 in regulating intestinal functions; (a) in resting conditions IL-38 maintains intestinal homeostasis, driving WNT3a production and organoid budding, whereas (b) in highly inflamed conditions, IL-38 contributes to proper recovery, by exerting anti-inflammatory activities. Thus, we demonstrate a pivotal role of IL-38 in driving tissue turnover and maintenance of homeostasis in intestinal health.
Publisher
Cold Spring Harbor Laboratory
Reference53 articles.
1. D. M. de Graaf , L. U. Teufel , L. A. B. Joosten , C. A. Dinarello , Interleukin-38 in Health and Disease. Cytokine 152, 155824 (2022).
2. C. Xie , et al., Interleukin-38 is elevated in inflammatory bowel diseases and suppresses intestinal inflammation. Cytokine 127, 154963 (2020).
3. Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel Disease;Biomed Res. Int,2018
4. The enigmatic role of IL-38 in inflammatory diseases;Cytokine Growth Factor Rev,2018
5. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist